drugset / Trial / NCT00045357
Biological Therapy in Treating Patients With Metastatic Melanoma
Phase 1
Completed
18 enrolled
Fred Hutchinson Cancer Center
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Biological therapies use different ways to stimulate the immune system and stop tumor cells from growing. Treating a person's white blood cells in the laboratory and reinfusing them may cause a stronger immune response and kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of biological therapy in treating patients who have metastatic melanoma.
Timeline
- Start
- 2001-11
- Primary completion
- —
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous CD4+ antigen-specific T-cells | Cell therapy | — | Intravenous |